CISCRP Explores Impact of COVID-19 on Clinical Research
The recent public healthcare crisis has generated an increasing amount of attention on the topic of clinical research. CISCRP has conducted a survey among the public and patients in April 2020 to assess the impact of the pandemic on clinical research perceptions and experiences. Individuals in the United States and a few select countries in Europe completed the survey.
For the survey’s findings, click here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
STEP UP Trial Shows Semaglutide 7.2 mg Achieves Superior Weight Loss vs. 2.4 mg, Placebo
January 17th 2025Semaglutide 7.2 mg significantly outperformed semaglutide 2.4 mg and placebo with a 20.7% average reduction in weight and a comparable safety and tolerability profile, further establishing its efficacy in obesity treatment.
